EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Regulatory T cells in dominant immunologic tolerance

Peter Georgiev, Mehdi Benamar, SeongJun Han, Marcia C Haigis, Arlene H Sharpe, Talal A Chatila

Journal of Allergy and Clinical Immunology · 2024

DOI: 10.1016/j.jaci.2023.09.025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024. Verfasst von Peter Georgiev und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, Mass; Department of Immunology, Blavatnik Institute, Harvard Medical…. Hauptthemen laut MEDLINE: Immune System Diseases, Autoimmune Diseases. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Regulatory T cells expressing the transcription factor forkhead box protein 3 mediate peripheral immune tolerance both to self-antigens and to the commensal flora. Their defective function due to inborn errors of immunity or acquired insults is associated with a broad range of autoimmune and immune dysregulatory diseases. Although their function in suppressing autoimmunity and enforcing commensalism is established, a broader role for regulatory T cells in tissue repair and metabolic regulation has emerged, enabled by unique programs of tissue adaptability and specialization. In this review, we focus on the myriad roles played by regulatory T cells in immunologic tolerance and host homeostasis and the potential to harness these cells in novel therapeutic approaches to human diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune System DiseasesAutoimmune DiseasesHumansT-Lymphocytes, RegulatoryImmune ToleranceAutoimmunityForkhead Transcription Factors

Stichwörter der Autor:innen

Foxp3IL-2Regulatory T cellsautoimmunityimmunologic toleranceregulatory T-cell therapy

Substanzen

Forkhead Transcription Factors

Autor:innen und Institutionen

  • Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, Mass; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Mass.
  • Division of Immunology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass.
  • Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, Mass.
  • Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, Mass.
  • Division of Immunology, Boston Children's Hospital, Boston, Mass; Department of Pediatrics, Harvard Medical School, Boston, Mass. Electronic address: talal.chatila@childrens.harvard.edu.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • NIAID
  • NIDDK

Zitieren

APA

Georgiev, P., Benamar, M., Han, S., Haigis, M. C., Sharpe, A. H., & Chatila, T. A. (2024). Regulatory T cells in dominant immunologic tolerance. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2023.09.025

Vancouver

Georgiev P, Benamar M, Han S, Haigis MC, Sharpe AH, Chatila TA. Regulatory T cells in dominant immunologic tolerance. Journal of Allergy and Clinical Immunology. 2024. doi:10.1016/j.jaci.2023.09.025

BibTeX
@article{Georgiev2024,
  author = {Georgiev, Peter and Benamar, Mehdi and Han, SeongJun and Haigis, Marcia C and Sharpe, Arlene H and Chatila, Talal A},
  title = {Regulatory T cells in dominant immunologic tolerance},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2024},
  doi = {10.1016/j.jaci.2023.09.025}
}
Kostenlos starten →